Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Value chain stages
Value chain stages
Finished Product
Products 21 to 30 of 171
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Balletic Foods Clean Meat
by
Balletic Foods
Biotech components:
N/A
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/07/02 11:19 (6 years ago)
Date last modified:
2019/07/02 11:19 (6 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
Industry:
Food & Agriculture
Market status:
Under Development
+
More information needed
Organization type(s):
Private Company
Product categories:
Food
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Beef
by
Memphis Meats
Biotech components:
Animal
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/02 11:48 (7 years ago)
Known funding amount:
20,100,000 USD
Funding types:
Venture Capital
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Food
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Biftek Cellular Meat
by
Biftek
Biotech components:
Animal
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/07/02 11:19 (6 years ago)
Date last modified:
2019/07/02 11:19 (6 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Food & Agriculture
Market status:
Early Stage Concept
+
More information needed
Organization type(s):
Private Company
Product categories:
Food
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Bio-dispertants
by
Modular Genetics, Inc.
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Government
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
1,225,000
Funding types:
Private Funding
+
Government
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
BIO-SA Based Personal Care Products
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2C
Country of production:
Canada
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/11/08 14:29 (7 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Personal Care
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Finished Product
BIO-SA Based Resins & Coatings
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2C
Country of production:
Canada
Country of distribution:
Benelux
+
France
+
Iberia
+
Germany
+
Poland
+
Switzerland
+
UK
+
Ireland
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/11/08 14:30 (7 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Finished Product
BIO-SA Based Solvents
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2C
Country of production:
Canada
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/11/09 16:31 (7 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Finished Product
BIO-SA De-icing solutions
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2C
Country of production:
Canada
Country of distribution:
North America
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/11/08 14:26 (7 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Finished Product
bioCement
by
bioMason
Biotech components:
Bacteria
Business models:
B2B
+
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/08 14:47 (7 years ago)
Known funding amount:
2,800,000 USD
Funding types:
Foundation
+
Government
+
University
+
Venture Capital
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Construction
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
BioDirect Technology: RNAi pest control solution
by
Monsanto
Biotech components:
Enzyme
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Plant
Production process:
Open Release
Source:
NASEM Database
Trading symbol:
MON
(NYSE)
Value chain stage:
Finished Product
1
2
3
4
5
6
7
8
9
10
…
18
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
